InvestorsObserver
×
News Home

Can Nuvation Bio Inc (NUVB) Stock Rise to the Top of Healthcare Sector Thursday?

Thursday, July 27, 2023 01:54 PM | InvestorsObserver Analysts

Mentioned in this article

Can Nuvation Bio Inc (NUVB) Stock Rise to the Top of Healthcare Sector Thursday?

Nuvation Bio Inc (NUVB) is near the middle in its sector according to InvestorsObserver. NUVB gets an overall rating of 10. That means it scores higher than 10% of stocks. Nuvation Bio Inc gets a 65 rank in the Healthcare sector. Healthcare is number 5 out of 11 sectors.

Overall Score - 10
NUVB has an Overall Score of 10. Find out what this means to you and get the rest of the rankings on NUVB!

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 10 means the stock is more attractive than 10 percent of stocks. Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With Nuvation Bio Inc Stock Today?

Nuvation Bio Inc (NUVB) stock has fallen -4.97% while the S&P 500 has gained 0.14% as of 1:53 PM on Thursday, Jul 27. NUVB is down -$0.09 from the previous closing price of $1.81 on volume of 779,974 shares. Over the past year the S&P 500 is up 13.65% while NUVB is down -45.05%. NUVB lost -$0.48 per share the over the last 12 months. Click Here to get the full Stock Report for Nuvation Bio Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App